Worldwide, there are more than 657,000+ cases and nearly 330,000 deaths from oral and oropharyngeal cancer each year. In the US alone, oral and oropharyngeal cancer kills on average 1 person per hour, 24 hours per day.1 The death rate associated with oral cancer is particularly high due to late–stage diagnosis, but early intervention can more than double a patient’s chance of survival.
Vigilant Biosciences® develops advanced and accurate methods to aid in the early detection of oral and oropharyngeal cancer through the identification of CD44 and total protein collected in a saline solution.
Anyone can be diagnosed with oral cancer, which includes cancer of the mouth, lip and throat. Certain factors can increase your risk.
Early diagnosis can double your chances of survival. Oral Cancer is often detected too late, when treatment is difficult. Early detection and intervention are critical, and now it is easier than ever.
Easily Identify the Presence of Biomarkers Associated with
Oral Cancer in just 10 Minutes